Business

Paulson buys more than 6M shares of Allergan stock

Valeant’s $53 billion hostile takeover for Botox maker Allergan has another hedge-fund heavyweight besides Bill Ackman on its side.

John Paulson, a Valeant shareholder, has taken an even bigger big stake in Allergan, sources told The Post.

Paulson has bought more than 6 million shares of Allergan, according to Reuters, which first reported the hedgie’s big stake.

Paulson did not return a call for comment.

The hedgie owned 1 million shares of Valeant at the end of the first quarter, according to regulatory filings.

The bigger Allergan stake would give Paulson, who is known for his merger bets, more than 2 percent of the Botox maker.

Combined with Ackman’s 9.7 percent, that comes to almost half of the 25 percent of shareholders needed to sign off on a special shareholders meeting to oust most of Allergan’s board of directors.

Ackman’s Pershing Square has called for the meeting to elect six new board members, given the snub Valeant’s offer has received from Allergan.